These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 416834)

  • 1. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)].
    Cerisola JA; Neves da Silva N; Prata A; Schenone H; Rohwedder R
    Bol Chil Parasitol; 1977; 32(3-4):51-62. PubMed ID: 416834
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of antibody dependent cytotoxicity to Trypanosoma cruzi in chronic chagasic mice after treatment with nifurtimox.
    Chambó JG; Cabeza Meckert PM; Laguens RP
    Medicina (B Aires); 1988; 48(1):49-53. PubMed ID: 3146009
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diurnal and nocturnal positivity of the xenodiagnosis in a patient with chronic chagasic infection and permanent parasitemia (author's transl)].
    Schenone H; Rojo M; Rojas A; Concha L
    Bol Chil Parasitol; 1977; 32(3-4):63-6. PubMed ID: 416835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiologic therapy of Chagas' disease].
    Boainain E; Rassi A
    Arq Bras Cardiol; 1979 Jun; 32(6):395-9. PubMed ID: 116629
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas infection].
    Schenone H; Rojas A; Alfaro E; Concha L; Aranda R
    Bol Chil Parasitol; 1981; 36(3-4):59-62. PubMed ID: 6812600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
    Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
    Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Chagas' disease with nifurtimox during the first months of life].
    Moya PR; Paolasso RD; Blanco S; Lapasset M; Sanmartino C; Basso B; Moretti E; Cura D
    Medicina (B Aires); 1985; 45(5):553-8. PubMed ID: 3939553
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response.
    Cabeza Meckert P; Chambó JG; Laguens RP
    Antimicrob Agents Chemother; 1988 Feb; 32(2):241-5. PubMed ID: 3129986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi.
    Haberkorn A; Gönnert R
    Arzneimittelforschung; 1972 Sep; 22(9):1570-82. PubMed ID: 4630483
    [No Abstract]   [Full Text] [Related]  

  • 12. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of length of treatment with Bayer 2502 on isolation of Trypanosoma cruzi and resistance to challenge in the mouse.
    Morrow DT; Wescott RB; Davis WC
    Am J Trop Med Hyg; 1977 May; 26(3):382-6. PubMed ID: 405877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nifurtimox treatment of chronic Chagasic infection in children].
    Schenone H; Contreras M; Solari A; García A; Rojas A; Lorca M
    Rev Med Chil; 2003 Sep; 131(9):1089-90. PubMed ID: 14635599
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical therapeutic trial in chronic Chagas' disease using nifurtimox in 3 schedules of long duration].
    Cancado JA; Salgado AA; Marra UD; Alvares JM; Machado JR
    Rev Inst Med Trop Sao Paulo; 1975; 17(2):111-27. PubMed ID: 807963
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yield of xenodiagnosis and PCR in the evaluation of specific chemotherapy of Chagas' disease in children].
    Solari A; Contreras MC; Lorca M; García A; Salinas P; Ortíz S; Soto A; Arancibia C; Schenone H
    Bol Chil Parasitol; 1998; 53(1-2):27-30. PubMed ID: 9830721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibility of treatment in Chagas' disease].
    Prata A
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):140-2. PubMed ID: 98813
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR.
    Solari A; Ortíz S; Soto A; Arancibia C; Campillay R; Contreras M; Salinas P; Rojas A; Schenone H
    J Antimicrob Chemother; 2001 Oct; 48(4):515-9. PubMed ID: 11581230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).
    Lelchuk R; Cardoni RL; Fuks AS
    Clin Exp Immunol; 1977 Dec; 30(3):434-8. PubMed ID: 414867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.